Singapore-based EVX launches Nuevocor with $24M series A to advance cardiomyopathy gene therapy pipeline

EVX Ventures has introduced another player into Singapore’s growing life sciences ecosystem with the launch of gene therapy company Nuevocor.

On Friday, Nuevocor Pte. Ltd. raised $24 million in a series A round co-led by EVX and Boehringer Ingelheim Venture Fund. EDBI, Xora Innovation, SEEDS Capital and other undisclosed investors also participated. ...